Sato 1997.

Methods	Double‐blind randomised study 64 of 84 completed
Participants	University Hospital, Japan 84 hospital outpatients who had hemiplegia after stroke. Analysis based on 64 completing participants, (35 men, 29 women) of mean age 68.5 years Disease exclusions: shoulder‐hand syndrome, multiple strokes, history of hip fracture, stroke duration < 1 month Drug exclusions: use of oestrogen, calcium, vitamin D, corticosteroids, thyroxine, or anticonvulsants
Interventions	1. 1‐alpha‐hydroxyvitamin D3 1.0 μg daily Randomised 45, completed 30 2. Identical placebo Randomised 39, 34 completed Both groups received 300 mg calcium daily Duration of treatment 6 months
Outcomes	Measured at 6 months 1. Number of participants sustaining a hip fracture Also measured, but not considered in this review were bone mineral density, and biochemical measures
Notes	Emailed Dr Sato 14 October 2005 asking for further details of deaths during the study. Awaiting further clarification with regard to methods